Available from our 503A patient specific pharmacy.
Click here to download the product insert.
| Classification | Injection |
|---|---|
| Sub-classification | Solution |
| Strength (Concentration) common dose* | 50mg/ml |
| Size (Volume) | 30ml |
*For professional use only. ImprimisRx® Pharmacy specializes in customizing medications to meet unique patient and practitioner needs. ImprimisRx® dispenses only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.
Potential Ingredient Risks
Possible Indications: Taurine is indicated in those with congestive heart failure (CHF), liver disease (hepatitis), retinal disorder, chemotherapy side effects, cirrhosis, cystic fibrosis, diabetes, fatigue, high blood pressure, mental performance, insomnia, psychosis and anemia.
Possible Adverse Effects: No noted side effects when dosed within normal limits.
Potential Contraindications/Precautions: Recommended dosage if taurine is less than 3,000 mg/day. Dosage is different for each treatment. Several mediations may cause interactions with Taurine. Lithium may have a diuretic effect, Antiplatelets/ Anticoagulants may lower the clotting effect leading to bleeding, NSAIDs / Salicylates may lead to changed clotting times and bleeding.
Storage: Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) (See USP Controlled Room Temperature).
